BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 24780945)

  • 1. Liver transplantation of hepatitis B surface antigen positive donors to hepatitis B core antibody recipients: analysis of 27 patients.
    Krishnamoorthi R; Manickam P; Cappell MS
    Minerva Gastroenterol Dietol; 2014 Jun; 60(2):113-8. PubMed ID: 24780945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of recipient or donor hepatitis B seropositivity in thoracic transplantation: analysis of 426 hepatitis B surface antigen-positive recipients.
    Manickam P; Krishnamoorthi R; Kanaan Z; Gunasekaran PK; Cappell MS
    Transpl Infect Dis; 2014 Aug; 16(4):597-604. PubMed ID: 24980920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.
    Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
    Transplant Proc; 2012 Sep; 44(7):1963-5. PubMed ID: 22974883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.
    Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
    Transplant Proc; 2012 Sep; 44(7):1960-2. PubMed ID: 22974882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
    Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
    J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of de novo hepatitis B with adefovir dipivoxil in recipients of liver grafts from hepatitis B core antibody-positive donors.
    Chang MS; Olsen SK; Pichardo EM; Heese S; Stiles JB; Abdelmessih R; Verna EC; Guarrera JV; Emond JC; Brown RS
    Liver Transpl; 2012 Jul; 18(7):834-8. PubMed ID: 22422699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database.
    Dhillon GS; Levitt J; Mallidi H; Valentine VG; Gupta MR; Sista R; Weill D
    Transplantation; 2009 Sep; 88(6):842-6. PubMed ID: 19920785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor.
    Yu L; Koepsell T; Manhart L; Ioannou G
    Liver Transpl; 2009 Oct; 15(10):1343-50. PubMed ID: 19790164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
    Angelico M; Cillo U; Fagiuoli S; Gasbarrini A; Gavrila C; Marianelli T; Costa AN; Nardi A; Strazzabosco M; Burra P; Agnes S; Baccarani U; Calise F; Colledan M; Cuomo O; De Carlis L; Donataccio M; Ettorre GM; Gerunda GE; Gridelli B; Lupo L; Mazzaferro V; Pinna A; Risaliti A; Salizzoni M; Tisone G; Valente U; Rossi G; Rossi M; Zamboni F;
    Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
    Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
    Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
    Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; Grossi P; Costa AN; Pinna AD; Brander C; Andreone P
    J Hepatol; 2012 Mar; 56(3):579-85. PubMed ID: 22027583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Chang MS; Olsen SK; Pichardo EM; Stiles JB; Rosenthal-Cogan L; Brubaker WD; Guarrera JV; Emond JC; Brown RS
    Transplantation; 2013 Apr; 95(7):960-5. PubMed ID: 23545507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
    Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
    Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
    Bohorquez HE; Cohen AJ; Girgrah N; Bruce DS; Carmody IC; Joshi S; Reichman TW; Therapondos G; Mason AL; Loss GE
    Liver Transpl; 2013 Jun; 19(6):611-8. PubMed ID: 23526668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
    Wachs ME; Amend WJ; Ascher NL; Bretan PN; Emond J; Lake JR; Melzer JS; Roberts JP; Tomlanovich SJ; Vincenti F
    Transplantation; 1995 Jan; 59(2):230-4. PubMed ID: 7839446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of hepatitis B surface antigen-positive grafts in liver transplantation: a matched analysis of the US National database.
    Li Z; Hu Z; Xiang J; Zhou J; Yan S; Wu J; Zhou L; Zheng S
    Liver Transpl; 2014 Jan; 20(1):35-45. PubMed ID: 24142889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.